Plasma thrombopoietin levels in marrow transplant patients with veno-occlusive disease of the liver

Bone Marrow Transplantation

Volumn 22, Issue 7, 1998, Pages 675-679

  Oh, H ^a   Tahara, T ^b   Bouvier, M ^c   Farrand, A ^c   McDonald, G B ^c,d  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cytoreductive therapy; Marrow transplantation; Platelets; Thrombocytopenia; Thrombopoietin; Venoocclusive disease

Indexed keywords

THROMBOPOIETIN;

ADULT; ARTICLE; BLOOD LEVEL; BONE MARROW TRANSPLANTATION; CELL SIZE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LIVER; LIVER VENOOCCLUSIVE DISEASE; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGRESSION ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0031734235     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701402     Document Type: Article

References (31)

1. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
2. Shulman HM, Fisher LB, Schoch HG et al. Venocclusive disease of the liver after marrow transplantation: histologic correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171-1180.
3. McDonald GB, Hinds MS, Fisher LB et al. Venocclusive dis ease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
4. Rio B, Andreu G, Nicod A et al. Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy. Blood 1986; 67: 1773-1776.
5. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1997; 89: 101-107.
6. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1996; 86: 419-431.
7. Hamaguchi M, Yamada H, Morishima Y et al. Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versushost disease and hepatic veno-occlusive disease. Int J Hematol 1996; 64: 241-248.
8. Ishida A, Miyakawa Y, Tanosaki R et al. Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation. Int J Hematol 1996; 65: 61-69.
9. Shimazaki C, Inaba T, Uchiyama H et al. Serum thrombopoietin levels in patients undergoing autologous peripheral blood Stem cell transplantation. Bone Marrow Transplant 1997; 19: 771-775.
10. Clift RA, Buckner CD, Thomas ED et al. Marrow transplantation for chronic myeloid leukemia. A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036-2043.
11. Tahara T, Usuki K, Sato H et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br J Haematol 1996; 93: 783-788.
12. Fink J, Cooper M, Burkhart K et al. Marked enzymuria following bone marrow transplantation: a correlate of venoocclusive disease-induced 'hepatorenal syndrome'. J Am Soc Nephrol 1995; 6: 1655-1660.
13. Shimodaira S, Ishida F, Ichikawa N et al. Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haem 1996; 76: 545-548.
14. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720-2730.
15. Meng YG, Martin TG, Peterson ML et al. Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. Br J Haematol 1996; 95: 535-541.
16. Nichol JL. Serum levels of thrombopoietin in health and disease. In: Kuter DJ, Hunt P, Sheridan W, Zucker-Franklin D (eds). Thrombopoiesis and Thrombopoietins: Molecular, Cellular, Preclinical, and Clinical Biology. Human Press: Totowa, NJ, 1997, pp 359-375.
17. Chang M, Suen Y, Meng G et al. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood 1996; 88: 3354-3362.
18. Schrezenmeier H, Griesshammer M, Hornkohl A et al. Endogenous thrombopoietin (TPO) levels in serum of patients with aplastic anemia (AA). Exp Hematol 1996; 24: 237 (Abstr.).
19. McCarty JM, Sprugel KH, Fox NE et al. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668-3675.
20. Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567-573.
21. Emmons RV, Reid DM, Cohen RL et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996; 87: 4068-4071.
22. Fajardo LF, Colby TV. Pathogenesis of veno-occlusive liver disease after radiation. Arch Path Lab Med 1980; 104: 584-588.
23. Shulman HM, Gown AM, Nugent DJ. Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987; 127: 549-558.
24. Carreras E, Granena A, Navasa M et al. Transjugular liver biopsy in bone marrow transplantation. Bone Marrow Transplant 1993; 11: 21-26.
25. Shulman HM, Gooley T, Dudley MD et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995; 59: 1015-1022.
26. O'Malley CJ, Rasko JE, Basser RL et al. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 1996; 88: 3288-3298.
27. Oda A, Miyakawa Y, Druker BJ et al. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 1996; 87: 4664-4670.
28. Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood 1995; 86: 4054-4062.
29. Miyakawa Y, Oda A. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Jpn J Clin Hematol 1996; 37: 785-790.
30. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haem 1993; 70: 119-123.
31. Harker LA, Marzec UM, Hunt P et al. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood 1996; 88: 511-521.